Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
4.110
+0.060 (1.48%)
At close: Nov 18, 2026, 4:00 PM EST
4.110
0.00 (0.00%)
Pre-market: Nov 19, 2026, 4:14 AM EST
Arbutus Biopharma Market Cap
Arbutus Biopharma has a market cap or net worth of $630.03 million as of November 18, 2026. It is the 12,474th most valuable company in the world and the 2,508th biggest in the United States. Its market cap has decreased by 27.85% in one year.
Market Cap
630.03M
Enterprise Value
295.85M
1-Year Change
-27.85%
Global Rank
Country Rank
#2,508 United States
Category
ChartMarket Cap Chart
Since December 31, 2009, Arbutus Biopharma's market cap has increased from $47.50M to $630.03M, an increase of 1,226.39%. That is a compound annual growth rate of 16.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 630.00M | -31.90% |
| Dec 31, 2025 | 925.10M | 49.31% |
| Dec 31, 2024 | 619.60M | 47.81% |
| Dec 29, 2023 | 419.20M | 14.98% |
| Dec 30, 2022 | 364.60M | -30.71% |
| Dec 31, 2021 | 526.20M | 74.59% |
| Dec 31, 2020 | 301.40M | 90.76% |
| Dec 31, 2019 | 158.00M | -25.65% |
| Dec 31, 2018 | 212.50M | -23.56% |
| Dec 29, 2017 | 278.00M | 106.85% |
| Dec 30, 2016 | 134.40M | -44.65% |
| Dec 31, 2015 | 242.80M | -28.19% |
| Dec 31, 2014 | 338.10M | 196.58% |
| Dec 31, 2013 | 114.00M | 89.05% |
| Dec 31, 2012 | 60.30M | 289.03% |
| Dec 30, 2011 | 15.50M | -68.04% |
| Dec 31, 2010 | 48.50M | 2.11% |
| Dec 31, 2009 | 47.50M | - |
| Dec 31, 2009 | 47.50M | - |
View and export this data all the way back to 2009. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Janux Therapeutics | 632.02M |
| Olema Oncology | 630.77M |
| Bicara Therapeutics | 622.05M |
| Geron | 621.95M |
| Design Therapeutics | 612.83M |
| Surrozen | 607.30M |
| Immix Biopharma | 597.58M |
| Alumis | 591.98M |